Search results
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 16 hours agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor...
Justice Department Opts Not to Charge Merck KGaA Subsidiary Over Export Controls Scheme
The Wall Street Journal· 2 days agoTwo men, including a former employee of the German company’s subsidiary, MilliporeSigma, pleaded...
Why This Top 4% Biotech Just Catapulted To A Record High
Investor's Business Daily· 15 hours agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's (MRK) cancer blockbuster,...
Justice Department Opts Not to Charge Merck KGaA Subsidiary Over Export Controls Scheme
The Wall Street Journal· 2 days agoTwo men, including a former employee of the German company’s subsidiary, MilliporeSigma, pleaded...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks· 1 day agoFree Report) announced updated clinical results from a cohort of the phase II IOV-COM-202 study evaluating the combination of its recently approved cell therapy Amtagvi and Merck< ...
I Couldn’t Escape Poison Oak. So I Started Eating It.
The Wall Street Journal· 7 days agoBy that decade, a raft of poison-ivy-extract pills and shots could be purchased from companies...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 17 hours ago(For example, it helps drug companies manage their clinical trials.) Its myriad customers include...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 1 day agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Healthcare data company Atropos Health receives $33m in Series B funding round
Hospital Management via Yahoo Finance· 19 hours agoThe funding round involved participation from both new and existing investors, including McKesson...
Nvidia's split of soaring stock could boost retail investor appeal, Dow chances
Reuters· 19 hours ago, opens new tab plan to split its stock after the stunning rise in the chipmaker's share price could...